Alphatec IPO Funding Projects Include Minimally Invasive Spinal Fusion System
This article was originally published in The Gray Sheet
Executive Summary
Spinal fusion system maker Alphatec plans to devote a portion of the net proceeds from its June 2 initial public offering to develop a minimally invasive spinal fusion system and bolster its sales force
You may also be interested in...
Orthopedics In Brief
Medtronic set to begin spinal stabilization trial: Firm is enrolling patients for the first of three clinical trials evaluating the use of its Diam spinal stabilization system. Medtronic announced IDE clearance to begin studies of the nonfusion spinal stabilization system on July 10. Diam relieves spine pressure by rerouting spinal load, similar to St. Francis Medical's X-Stop device, PMA approved in 2005. Medtronic's initial study, slated to begin in August, will examine the safety and effectiveness of the Diam system in patients with degenerative stenosis. The second trial, to begin in Europe in September, will compare discectomy with Diam to discectomy alone. A third study will evaluate Diam's use in degenerative disc disease. Medtronic expects to enroll a total of 430 patients in up to 25 centers in the U.S. and Europe...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.